These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11649590)
41. Mack v. Califano. 23 Feb 1978. U.S. District Court, District of Columbia Fed Suppl; 1978; 447():668-71. PubMed ID: 11645921 [No Abstract] [Full Text] [Related]
42. Drug firms becoming active in DNA research. Rawls RL Chem Eng News; 1977 Jul; 55(29):19-20. PubMed ID: 11662412 [No Abstract] [Full Text] [Related]
44. Recombinant DNA controversy. Johnson AW Science; 1977 Oct; 198(4313):123-4. PubMed ID: 11643402 [No Abstract] [Full Text] [Related]
45. Recombinant DNA guidelines: scientific and political questions. Rowe WP Science; 1977 Nov; 198(4317):563, 565. PubMed ID: 11643413 [No Abstract] [Full Text] [Related]
46. Dutch go ahead on DNA. Schuuring C Nature; 1977 Apr; 266(5604):671. PubMed ID: 11643381 [No Abstract] [Full Text] [Related]
47. Ordinance for the use of recombinant DNA molecule technology in the City of Cambridge. Cambridge, Massachusetts. City Council Camb Munic Code 1988 Camb Mass; 1977; Chapter 11 Article II():. PubMed ID: 12041502 [No Abstract] [Full Text] [Related]
48. Sweden debates gene-splicing. Barnaby W Nature; 1977 Dec 22-29; 270(5639):653. PubMed ID: 11661514 [No Abstract] [Full Text] [Related]
49. Warning over bacterial research; other countries urged to adopt British guidelines. Dickson D Times (Lond); 1976 Oct; ():4. PubMed ID: 11648646 [No Abstract] [Full Text] [Related]
50. Meeting of the large-scale review working group of the Recombinant DNA Advisory Committee. Recomb DNA Tech Bull; 1982 Mar; 5(1):29-33. PubMed ID: 7071379 [No Abstract] [Full Text] [Related]
51. Safety exemptions suspended for firms in genetic research. Cohn V Washington Post; 1977 Feb; ():A10. PubMed ID: 11648693 [No Abstract] [Full Text] [Related]
52. DNA recombination forces resignation. Dickson D Nature; 1980 Sep; 287(5779):179-80. PubMed ID: 7432453 [No Abstract] [Full Text] [Related]
53. NIOSH perspective on commercial recombinant DNA/biotechnology development. Pauker S Recomb DNA Tech Bull; 1981 Jul; 4(2):61-4. PubMed ID: 7255759 [No Abstract] [Full Text] [Related]
54. [Recommendations for preventing transmission of infection with biohazard in the practice of legal medicine (2). Equipment and practical applications. The Medico-Legal Society of Japan, Committee on Expert Opinions]. Takahama K; Ishizu H; Oshida S; Komura S; Sagisaka K; Tanaka N; Tsunenari S; Matoba R Nihon Hoigaku Zasshi; 1994 Apr; 48(2):105-10. PubMed ID: 8196209 [TBL] [Abstract][Full Text] [Related]
59. GOVERNMENT TORT LIABILITY UNDER THE DRUG AMENDMENTS OF 1962. STETLER CJ J New Drugs; 1963; 3(5):266-75. PubMed ID: 14089802 [No Abstract] [Full Text] [Related]
60. Legal responsibilities of the university as a community. The present status of in loco parentis. Kimble WE J Am Coll Health Assoc; 1969 Feb; 17(3):222-6. PubMed ID: 5792315 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]